Imming (Beijing) Cell Biotechnology (Yiming cells)
Developing biological drugs.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD213m (Public information from Apr 2023)
Beijing China (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
N/A | Seed | ||
CNY120m | Series A | ||
CNY200m | Series B | ||
CNY200m | Series C | ||
* | CNY150m Valuation: CNY1.0b | Series C | |
Total Funding | AUD142m |